The 2017 ASCP Annual Meeting Evaluation is now available. Please click to complete the evaluation and apply for CME/CE/MOC hours. For more information click here.
Join ASCP today and become part of an organization dedicated to advance the science and practice of clinical psychopharmacology. Members benefits from discounted registration to ASCP’s Annual Meeting, Psychopharmacology Update and Clinical Trials Workshop.
The ASCP Executive Office is monitoring the Centers for Disease Control information on the Zika Virus in South Florida. We encourage members and meeting attendees to stay informed on the latest information and CDC recommendations. Click here for the CDC website. Information specific about travel to South Florida can be found here.
The 2017 ASCP Annual Meeting was in Miami Beach, FL from May 29 - June 2, 2017. The meeting included representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that discussed key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Marlene Freeman and John Newcomer with representation of the sectors that are part of the ASCP community led the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprised the 2017 Steering Committee. A Program Committee under the leadership of Drs. Holly Swartz and Alan Gelenberg were responsible for the review of all program submissions.
We look forward to seeing you in Miami Beach in 2018!